- Tytuł:
- Adjuvant vs. progression-triggered treatment with gemcitabine in platinum-ineligible high-risk bladder cancer patients: Long-term follow-up of a randomized phase 3 trial
- Autorzy:
- Źródło:
- In Urologic Oncology: Seminars and Original Investigations August 2023 41(8):356-356
Czasopismo naukowe